Eevia Health Plc is experiencing a sharp spike in requests for prices and products as ripple effects from the U.S. imposed China tariffs, which now disrupt global nutraceutical supply chains. Several major U.S.-based companies are urgently seeking alternative sources for compendial plant-based ingredients—especially low-concentrate powders—to mitigate the risk of stockouts and margin pressure caused by […]
Read more...We are proud to announce our participation at Vitafoods 2025, the leading global nutraceutical trade show, taking place in Barcelona, Spain, 20–22 May 2025. During the event, Eevia will launch a new, innovative health ingredient and support the re-launch of a third ingredient in collaboration with a new partner. Vitafoods is the premier meeting place […]
Read more...Eevia Health has published a whitepaper summing a study that compares the bioequivalence between Fenoprolic® and Pycnogenol®, two leading pine bark extracts known for their high levels of oligomeric proanthocyanidins (OPCs). Fenoprolic® is derived from the bark of Arctic pine trees (Pinus sylvestris) sourced from the pristine forests of Finnish Lapland. This region’s pure environment ensures the highest quality raw materials, resulting in a potent […]
Read more...